NPI: 1457361271 · CHULA VISTA, CA 91910 · 207RH0003X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,250 | $3.07M |
| 2019 | 12,296 | $3.90M |
| 2020 | 6,730 | $1.26M |
| 2021 | 1,828 | $118K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J2505 | Injection, pegfilgrastim 6mg | 906 | 551 | $3.61M |
| J9355 | Inj trastuzumab excl biosimi | 785 | 437 | $3.17M |
| J1453 | Fosaprepitant injection | 1,554 | 806 | $398K |
| 99214 | 6,464 | 6,119 | $329K | |
| J9202 | Goserelin acetate implant | 452 | 407 | $217K |
| 96413 | 3,093 | 1,890 | $152K | |
| 96367 | 1,695 | 994 | $104K | |
| 96415 | 1,659 | 1,124 | $100K | |
| J2405 | Ondansetron hcl injection | 2,020 | 1,013 | $48K |
| 96372 | 1,427 | 742 | $38K | |
| 96417 | 917 | 668 | $31K | |
| 85025 | 5,480 | 3,716 | $25K | |
| J1442 | Inj filgrastim excl biosimil | 53 | 12 | $22K |
| J3489 | Zoledronic acid 1mg | 477 | 363 | $22K |
| 96368 | 1,484 | 864 | $21K | |
| J9171 | Docetaxel injection | 94 | 50 | $20K |
| J9070 | Cyclophosphamide 100 mg inj | 29 | 13 | $13K |
| J0885 | Epoetin alfa, non-esrd | 27 | 12 | $9K |
| J1100 | Dexamethasone sodium phos | 1,737 | 889 | $7K |
| 99211 | 440 | 352 | $6K | |
| 99205 | Prolong outpt/office vis | 44 | 44 | $5K |
| 99070 | 802 | 528 | $4K | |
| 96402 | 444 | 429 | $4K | |
| 96401 | 21 | 13 | $112.98 |